Efficacy of bevacizumab-based treatment in early-onset treatment-naive metastatic colorectal cancer patients: An ARCAD database analysis

被引：0
|
作者：
Jin, Zhaohui
Dixon, Jesse G.
Hubbard, Joleen M.
Eng, Cathy
Lieu, Christopher Hanyoung
Fiskum, Jack
Saltz, Leonard B.
Hurwitz, Herbert I.
Venook, Alan P.
Schmoll, Hans-Joachim
Fuchs, Charles S.
Hecht, J. Randolph Randolph
Cremolini, Chiara
Diaz-Rubio, Eduardo
Punt, Cornelis J. A.
Tebbutt, Niall C.
Heinemann, Volker
Yoshino, Takayuki
De Gramont, Aimery
Shi, Qian
机构：
[1] Univ Iowa, Iowa City, IA 52242 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[5] Univ Colorado, Ctr Canc, Aurora, CO USA
[6] Mem Sloan Kettering Canc Ctr, Dept Colorectal Oncol, 1275 York Ave, New York, NY 10021 USA
[7] Duke Univ, Sch Med, Durham, NC USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Martin Luther Univ Halle Wittenberg, Halle, Germany
[10] Yale Canc Ctr, New Haven, CT USA
[11] Smilow Canc Hosp, New Haven, CT USA
[12] UCLA, Los Angeles, CA USA
[13] Azienda Osped Univ, Pisana Ospedale Santa Chiara, Pisa, Italy
[14] Hosp Clin Univ San Carlos, Madrid, Spain
[15] Amsterdam UMC, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[16] Austin Hlth, Wellness & Res Ctr, Olivia Newton John Canc, Heidelberg, Vic, Australia
[17] Univ Hosp Munich, LMU Munich, Munich, Germany
[18] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[19] Franco British Inst, Levallois Perret, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
101
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Response to epithelial growth factor receptor inhibitor (EGFRi) treatment in patients with early-onset, treatment-naive metastatic colorectal cancer (mCRC): An ARCAD database analysis.
    Jin, Zhaohui
    Dixon, Jesse G.
    Hubbard, Joleen M.
    Eng, Cathy
    Lieu, Christopher Hanyoung
    Douillard, Jean-Yves
    Adams, Richard
    Maughan, Timothy S.
    Van Cutsem, Eric
    Venook, Alan P.
    Lenz, Heinz-Josef
    Heinemann, Volker
    Stintzing, Sebastian
    Kaplan, Richard S.
    Bokemeyer, Carsten
    Chibaudel, Benoist
    Zalcberg, John Raymond
    Yoshino, Takayuki
    De Gramont, Aimery
    Shi, Qian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
    Xu, Ran
    Xu, Chen
    Liu, Chuntong
    Cui, Can
    Zhu, Jing
    ONCOTARGETS AND THERAPY, 2018, 11 : 8605 - 8621
  • [3] Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
    Manzoni, M.
    Rovati, B.
    Ronzoni, M.
    Loupakis, F.
    Mariucci, S.
    Ricci, V.
    Gattoni, E.
    Salvatore, L.
    Tinelli, C.
    Villa, E.
    Danova, M.
    ONCOLOGY, 2010, 79 (3-4) : 187 - 196
  • [4] Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
    Strickler, John H.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2012, 17 (04): : 513 - 524
  • [5] The treatment-naive microbiome in early-onset Crohn's Disease
    Gevers, Dirk
    Kugathasan, Subra
    Denson, Lee
    Vazquez-Baeza, Yoshiki
    Van Treuren, Will
    Ren, Boyu
    Schwager, Emma
    Knights, Dan
    Song, Se Jin
    Yassour, Moran
    Morgan, Xochitl
    Kostic, Aleksandar D.
    Luo, Chengwei
    Gonzalez, Antonio
    McDonald, Daniel
    Haberman, Yael
    Walters, Thomas D.
    Baker, Susan S.
    Rosh, Joel R.
    Stephens, Michael C.
    Heyman, Melvin B.
    Markowitz, James
    Baldassano, Robert
    Griffiths, Anne M.
    Sylvester, Francisco A.
    Mack, David R.
    Kim, Sandra
    Crandall, Wallace
    Hyams, Jeffrey S.
    Huttenhower, Curtis
    Knight, Rob
    Xavier, Ramnik J.
    GASTROENTEROLOGY, 2014, 146 (05) : S144 - S144
  • [6] Survival Analysis of Metastatic Early-Onset Colorectal Cancer Compared to Metastatic Average-Onset Colorectal Cancer: A SEER Database Analysis
    Jeri-Yabar, Antoine
    Vittini-Hernandez, Liliana
    Prado-Nunez, Sebastian
    Dharmapuri, Sirish
    CANCERS, 2024, 16 (11)
  • [7] Sequential Bevacizumab-based therapy in metastatic colorectal cancer (mCRC): results of a treatment sequencing cost analysis
    Rautenberg, T.
    Siebert, U.
    Arnold, D.
    Bennouna, J.
    Kubicka, S.
    Walzer, S.
    Ngoh, C.
    ONKOLOGIE, 2012, 35 : 56 - 56
  • [8] An ARCAD database nomogram for prognostic prediction of treatment refractory metastatic colorectal cancer
    Oki, Eiji
    Bando, Hideaki
    Yamazaki, Kentaro
    Misumi, Toshihiro
    Takeda, Yuriko
    Suzuki, Motoko
    Wakabayashi, Masashi
    Wakabayashi, Masashi
    Grothey, Axel
    Mayer, Robert J.
    Li, Jin
    Andre, Thierry
    Shi, Qian
    De Gramont, Aimery
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 107 - 107
  • [9] Efficacy and safety of bevacizumab-based maintenance therapy in metastatic colorectal cancer A meta-analysis
    Ma, Hongbo
    Wu, Xiaoli
    Tao, Miaomiao
    Tang, Nan
    Li, Yanyan
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2019, 98 (50)
  • [10] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Cherciu, Nelly
    Petria, Cristina
    ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
12345